Nosocomial infection after septic shock among intensive care unit patients

Infection Control and Hospital Epidemiology

Volumn 29, Issue 11, 2008, Pages 1054-1065

  Landelle, Caroline ^b,d   Lepape, Alain ^a   Français, Adrien ^f   Tognet, Eve ^a   Thizy, Hélène ^c   Voirin, Nicolas ^b,d   Timsit, Jean François ^e,f   Monneret, Guillaume ^b   Vanhems, Philippe ^b,c  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ DE LYON   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f INSTITUT ALBERT BONNIOT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEPTIC SHOCK;

AGED; COHORT STUDIES; CROSS INFECTION; FEMALE; FRANCE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SHOCK, SEPTIC;

EID: 54949148407     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/591859     Document Type: Article

References (32)

1. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B, CUB-Réa Network. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med 2003; 168:165-172.
2. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:2078-2086.
3. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis: campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-873.
4. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 2003; 361:2068-2077.
5. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
6. Brawley RL, Weber DJ, Samsa GP, Rutala WA. Multiple nosocomial infections: an incidence study. Am J Epidemiol 1989; 130:769-780.
7. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28:108-121.
8. Roman-Marchant O, Orellana-Jimenez CE, De Backer D, Melot C, Vincent JL. Septic shock of early or late onset: does it matter? Chest 2004; 126:173-178.
9. Vanhems P, Lepape A, Savey A, Jambou P, Fabry J. Nosocomial pulmonary infection by antimicrobial-resistant bacteria of patients hospitalized in intensive care units: risk factors and survival. J Hosp Infect 2000; 45:98-106.
10. Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006; 32:1175-1183.
11. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians / Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829.
13. McCabe WA, Jackson GG. Gram negative bacteremia. Arch Intern Med 1962; 110:847-855.
14. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European / North American multicenter study. JAMA 1993; 270:2957-2963.
15. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596.
16. Hospitals in Europe Link for Infection Control through Surveillance (HELICS). Surveillance of Nosocomial Infections in Intensive Care Units: Master Protocol. Lyon, France: Hospitals in Europe Link for Infection Control through Surveillance; 2004. Available at: http://helics.univlyon1.fr/ helicshome.htm. Accessed January 24, 2008.
17. Estève J, Benhamou E, Raymond L. Techniques for the analysis of cancer risk. In: Estève J, Benhamou E, Raymond L, eds. Statistical Methods in Cancer Research IV: Descriptive Epidemiology. Lyon: IARC Scientific; 1994: 89.
18. Kalbfleish JD, Prentice RL. Multivariate failure time data and competing risks. In: Kalbfleish JD, Prentice RL, eds. The Statistical Analysis of Failure Time Data. New York: Wiley; 1980:163-188.
19. Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics 1990; 46:813-826.
20. Korn EL, Dorey FJ. Applications of crude incidence curves. Stat Med 1992; 11:813-829.
21. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics 1988; 16:1141-1154.
22. Alberti C, Metivier F, Landais P, Thervet E, Legendre C, Chevret S. Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. J Clin Epidemiol 2003; 56:536-545.
23. Fine J, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94:496-509.
24. R Development Core Team. R: a Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Available at: http://www.R-project.org/. Accessed January 24, 2008.
25. Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003; 31:462-467.
26. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18:695-706.
27. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993; 12:737-751.
28. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273:117-123.
29. Groupe Transversal Sepsis. Prise en charge initiale des états septiques graves de l'adulte et de l'enfant. France: Conférences d'experts; 2006.
30. Société Française d'Anesthésie et de Réanimation (SFAR). Prise en charge hémodynamique du sepsis sévère (nouveau-né exclu). France: Conférences de consensus organisées par la SFAR; 2005.
31. Société de Réanimation de Langue Française (SRLF). Corticothérapie au cours du choc septique et du SDRA. XXème conférence de consensus de la SRLF; 2000.
32. Société Française d'Anesthésie et de Réanimation (SFAR). Antibiothérapie probabiliste des états septiques graves. France: Conférence d'experts; 2004.